We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From May 2022 to May 2024
-- The largest shareholder in Bayer, Fonds Union, is discontent with lack of initiative from Supervisory Board chief Norbert Winkeljohann in regards to a spin-off of the company's consumer-health unit, German business paper WirtschaftsWoche reports.
-- Mr. Winkeljohann is seeking dialogue with investors, but he should have pushed more, as chief comptrollers at other companies such as Novartis or GSK are much more engaged to create value for shareholders, Portfolio Manager of Union Investment Markus Manns told the paper in an interview.
-- "It would definitely have been a matter for the board of directors to help initiate a spin-off of consumer health," Mr. Manns said in the interview.
Full story (in German): https://bit.ly/3Hoxbt3
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
January 23, 2023 04:34 ET (09:34 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
